Annual Shareholders Equity
$184.79 M
+$59.61 M+47.62%
December 31, 2023
Summary
- As of February 7, 2025, CGON annual stockholders equity is $184.79 million, with the most recent change of +$59.61 million (+47.62%) on December 31, 2023.
- During the last 3 years, CGON annual shareholders equity has risen by +$144.54 million (+359.08%).
- CGON annual shareholders equity is now at all-time high.
Performance
CGON Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$536.77 M
-$15.59 M-2.82%
September 30, 2024
Summary
- As of February 7, 2025, CGON quarterly stockholders equity is $536.77 million, with the most recent change of -$15.59 million (-2.82%) on September 30, 2024.
- Over the past year, CGON quarterly shareholders equity has dropped by -$32.17 million (-5.65%).
- CGON quarterly shareholders equity is now -5.65% below its all-time high of $568.94 million, reached on March 31, 2024.
Performance
CGON Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CGON Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +47.6% | -5.7% |
| 3 y3 years | +359.1% | - |
| 5 y5 years | +359.1% | - |
CGON Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +359.1% | -5.7% | +328.8% |
| 5 y | 5-year | at high | +359.1% | -5.7% | +328.8% |
| alltime | all time | at high | +359.1% | -5.7% | +328.8% |
CG Oncology Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $536.77 M(-2.8%) |
| Jun 2024 | - | $552.36 M(-2.9%) |
| Mar 2024 | - | $568.94 M(+207.9%) |
| Dec 2023 | $184.79 M | $184.79 M(-7.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $199.87 M(+59.7%) |
| Dec 2022 | $125.18 M(+211.0%) | - |
| Dec 2022 | - | $125.18 M |
| Dec 2021 | $40.25 M | - |
FAQ
- What is CG Oncology annual stockholders equity?
- What is the all time high annual shareholders equity for CG Oncology?
- What is CG Oncology annual shareholders equity year-on-year change?
- What is CG Oncology quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for CG Oncology?
- What is CG Oncology quarterly shareholders equity year-on-year change?
What is CG Oncology annual stockholders equity?
The current annual shareholders equity of CGON is $184.79 M
What is the all time high annual shareholders equity for CG Oncology?
CG Oncology all-time high annual stockholders equity is $184.79 M
What is CG Oncology annual shareholders equity year-on-year change?
Over the past year, CGON annual stockholders equity has changed by +$59.61 M (+47.62%)
What is CG Oncology quarterly stockholders equity?
The current quarterly shareholders equity of CGON is $536.77 M
What is the all time high quarterly shareholders equity for CG Oncology?
CG Oncology all-time high quarterly stockholders equity is $568.94 M
What is CG Oncology quarterly shareholders equity year-on-year change?
Over the past year, CGON quarterly stockholders equity has changed by -$32.17 M (-5.65%)